Revefenacin helps patients with moderate to severe COPD
Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability, investigation is essential for better management in both men and women.
A randomized trial by Gary Ferguson and team revealed that nebulized revefenacin produced significant improvements in COPD Assessment Test (CAT) scores in women and men with moderate to very severe COPD, they also revealed significant improvements in St George's Respiratory Questionnaire (SGRQ) scores in women alone when compared with placebo. Maintenance treatment with revefenacin can improve health status of patients with moderate to very severe COPD; however, the effect may be more pronounced in women than men.
For more details, check out the full story on the link below:
Nebulized Revefenacin Improves Health Status Of Patients With Moderate To Very Severe COPD: Study
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd